The Complex Relationship Between HDL/LDL Cholesterol, Stroke and Cardiovascular Disease
Healthcare · 17.05.2026 · 14 (10) · 1371
DOI: 10.3390/healthcare14101371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Healthcare, online erschienen am 17.05.2026. Verfasst von Mark Parker und 4 weiteren Autor:innen. Beteiligte Einrichtung: ZEM Solutions, 11050 Belgrade, Serbia. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Background and Aims: Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of mortality worldwide, with lipid abnormalities playing a central role in disease development. While the causal role of low-density lipoprotein cholesterol (LDL-C) in ASCVD is well-established, the long-term population impact of combined lipid profiles, particularly the HDL-C/LDL-C ratio, remains less clearly quantified. This study aimed to estimate the lifetime burden of cardiovascular outcomes associated with different lipid risk profiles using a patient-level simulation framework.
Methods
The authors analyzed projected lifetime ASCVD events across four HDL-C/LDL-C risk strata, ranging from low (≥0.45) to very high ( 5.0 mmol/L had a life expectancy 13.4 years shorter than those with LDL-C < 3.1 mmol/L. The burden of ASCVD increased exponentially with worsening lipid ratios: MI events rose from 5000 to 73,090 per 100,000 births, with onset in the highest risk group occurring as early as age 20. Ischaemic heart disease followed a similar pattern, showing up to 92% of events attributable to elevated lipid risk. While ischaemic stroke risk displayed a more complex pattern due to earlier MI mortality in high-risk groups, overall cardiovascular mortality and lifetime event burden were dominated by LDL-driven disease. These findings demonstrate that sustained LDL-C reduction and balanced HDL-C/LDL-C ratios confer substantial survival benefits across both sexes and all age groups.
Conclusions
This study shows that lipid balance has a decisive influence on cardiovascular survival. Sustained LDL-C reduction and favourable HDL-C/LDL-C ratios markedly extend life expectancy and delay the onset of MI and IHD. The magnitude of this survival benefit highlights the need for early and continuous lipid control as a cornerstone of ASCVD prevention. The NHM quantifies these lifetime effects, offering valuable insights for targeted strategies that improve both longevity and quality of life.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ZEM Solutions, 11050 Belgrade, Serbia.
- School of Public Health, Faculty of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
- OSTEBA-Basque Office for Health Technology Assessment, Health Research and Innovation Directorate, Ministry for Health, Basque Government, 01010 Vitoria-Gasteiz, Spain.
ORCID-Profile: Mark Parker, Vanesa Benković, Iñaki Gutierrez-Ibarluzea
Zitieren
APA
Parker, M., Novaković, T., Krga Rastović, M., Benković, V., & Gutierrez-Ibarluzea, I. (2026). The Complex Relationship Between HDL/LDL Cholesterol, Stroke and Cardiovascular Disease. Healthcare, 14(10), 1371. https://doi.org/10.3390/healthcare14101371
Vancouver
Parker M, Novaković T, Krga Rastović M, Benković V, Gutierrez-Ibarluzea I. The Complex Relationship Between HDL/LDL Cholesterol, Stroke and Cardiovascular Disease. Healthcare. 2026;14(10):1371. doi:10.3390/healthcare14101371
BibTeX
@article{Parker2026,
author = {Parker, Mark and Novaković, Tanja and Krga Rastović, Milica and Benković, Vanesa and Gutierrez-Ibarluzea, Iñaki},
title = {The Complex Relationship Between HDL/LDL Cholesterol, Stroke and Cardiovascular Disease},
journal = {Healthcare},
year = {2026},
volume = {14},
number = {10},
pages = {1371},
doi = {10.3390/healthcare14101371}
}
EUVIMED